Skip to main content

Table 1 General characteristics of sample at baseline by group *

From: The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics

 

Intervention groups

 

A

B

C

D

n

620

633

622

626

Age (years)

61.5 ± 9.3

61.4 ± 9.3

61.4 ± 8.7

61.4 ± 8.9

Gender

    

   - Men (%)

492 (79.3)

501 (79.1)

497 (79.9)

497 (79.4)

   - Women (%)

128 (20.7)

132 (20.9)

125 (20.1)

129 (20.6)

Inclusion criteria

    

   - myocardial infarction (%)

279 (45.0)

301 (47.5)

288 (46.3)

283 (45.2)

   - unstable angina (%)

176 (28.4)

184 (29.1)

168 (27.0)

183 (29.2)

   - stroke (%)

165 (26.6)

148 (23.4)

166 (26.7)

160 (25.6)

Level of education (%)

    

   Elementary school

374 (61.9)

364 (59.0)

369 (60.6)

376 (61.0)

   Secondary school

138 (22.9)

145 (23.5)

151 (24.8)

136 (22.1)

   University or equivalent

92 (15.2)

108 (17.5)

89 (14.6)

104 (16.9)

Smoking (%)

    

   Current smokers

69 (11.4)

69 (11.3)

67 (11.0)

63 (10.2)

   Former smokers

369 (61.2)

359 (58.8)

369 (60.7)

395 (63.7)

   Non-smokers

165 (27.4)

183 (29.9)

172 (28.3)

162 (26.1)

Blood pressure (mm Hg)

    

   systolic

133.1 ± 21.4

134.1 ± 21.9

133.5 ± 22.2

132.6 ± 20.0

   diastolic

83.6 ± 13.2

84.0 ± 12.9

84.0 ± 13.7

82.6 ± 12.1

Body mass index (Kg/m2)

27.6 ± 4.4

27.5 ± 4.0

27.7 ± 4.0

27.5 ± 3.8

Waist/Hip ratio

0.95 ± 0.07

0.95 ± 0.07

0.95 ± 0.07

0.95 ± 0.08

  1. * m ± SD, except if specified